Abstract
The effects of cannabinoid ligands were studied in rats responding under a repeated acquisition procedure. Each session rats were required to learn a different three-response sequence; every third correct completion of the sequence resulted in the presentation of a food pellet. Errors produced a brief timeout but did not reset the chain. Neither injections of the centrally inactive cannabinoid, cannabidiol (3.2–100 mg/kg i.p.), nor the endogenous ligand, anandamide (0.01–18 mg/kg i.p.), affected rate or accuracy of responding. In contrast, Δ9-tetrahydrocannabinol (3.2–18 mg/kg i.p.) and the long-acting analog of the endogenous ligand, R-methanandamide (1–18 mg/kg i.p.), produced dose-related increases in the total percentage of errors and decreases in the rate of responding. The brain cannabinoid receptor antagonist SR141716A (1–32 mg/kg) did not affect either accuracy or rate of responding when administered alone. A low dose of SR141716A (1 mg/kg), which had no effect when administered alone, antagonized the disruptive effects of Δ9-tetrahydrocannabinol and R-methanandamide on rate and accuracy of responding and produced an estimated 3-fold shift to the right in the dose-effect curves. However, administration of SR141716A did not alter the effects of morphine. These results suggest that cannabinoid agonists produce disruptions of learning in rats through stimulation of the cannabinoid receptor. The data further suggest that whereas cannabimimetic agents can disrupt learning, the anandaminergic system may not be tonically involved in learning.
Footnotes
-
Send reprint requests to: Dr. J. M. Moerschbaecher, LSU Medical Center, Department of Pharmacology and Experimental Therapeutics, 1901 Perdido St., New Orleans, LA 70112-1393.
-
↵1 This research was supported by United States Public Health Service Grants DA 03573 and DA 04775.
- Abbreviations:
- Δ9-THC
- Δ9-tetrahydrocannabinol
- SR
- SR141716A
- CB
- cannabinoid receptor, official designation for subtypes CB1 and CB2
- PMSF
- phenylmethylsulfonyl fluoride
- Received January 15, 1997.
- Accepted May 30, 1997.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|